Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness

Core Insights - Emergent BioSolutions Inc. highlights a rising concern among U.S. policy opinion leaders regarding the likelihood of biological attacks, with 65% agreeing on the increased risk, while 45% believe the U.S. is unprepared for such threats [1][4] - The survey indicates that biological threats are viewed as a top national security concern, surpassing nuclear threats, with 73% believing biological attacks would be easier to execute [2][4] Survey Findings - The survey conducted by Penta Group involved approximately 250 U.S. policy opinion leaders, revealing that nearly two-thirds (65%) perceive a rising likelihood of biological attacks, compared to 60% for nuclear threats [1][4] - A significant majority (73%) believe that a biological attack would be easier to carry out than a nuclear one, with 46% identifying biological attacks as more likely than nuclear attacks [4] - Almost 90% of respondents emphasize the necessity for the U.S. to maintain global leadership in researching and developing medicines for known biological threats [4] Company Positioning - Emergent BioSolutions, with over 25 years of experience in developing medical countermeasures, is well-positioned to support U.S. preparedness efforts against biological threats [2] - The company’s product portfolio addresses four Category A biological agents, which are considered the highest risk for biological attacks due to their potential ease of dissemination and high mortality rates [2][4] - Emergent has specialized manufacturing capabilities through its North American network, enabling the production of medical countermeasures for these infectious agents and toxins [2]